PPTDF (PeptiDream) Risk Assessment


PPTDF PeptiDream Inc PPTDF
76 GF Score
Price $6.00
GF Value $9.54
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is PeptiDream Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of PeptiDream is: High Risk: Good fundamentals, beware of shrinking business.

PeptiDream  (OTCPK:PPTDF) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

PeptiDream Risk Assessment Related Terms

PPTDF vs VRTX, REGN, ALNY: Risk Assessment Comparison

For the Biotechnology subindustry, PeptiDream's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PeptiDream Risk Assessment vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PeptiDream's Risk Assessment distribution charts can be found below:

* The bar in red indicates where PeptiDream's Risk Assessment falls into.


PPTDF
76GF Score
PeptiDream Inc PPTDF
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PeptiDream (PPTDF) Overvalued in 2026?

Based on GuruFocus' analysis, PeptiDream stock appears to be undervalued. The current stock price of $6.00 is trading 37.1% below its estimated GF Value™ of $9.54. GuruFocus considers PeptiDream to be Possible Value Trap.

Key valuation signals for PPTDF:

  • Risk Assessment:
  • GF Value™: $9.54 vs. price of $6.00 (37.1% below fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the PPTDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PeptiDream Business Description

Other Exchanges 4587:Japan
Address 3-25-23 Tonomachi, Kawasaki-ku, Kanagawa Prefecture, Kawasaki, JPN, 210-0821
PeptiDream Inc is engaged in the drug discovery and development business. The group utilizes PDPS, its proprietary drug discovery and development platform system, for drug discovery and development, and it conducts radiopharmaceutical business through a wholly owned subsidiary and is involved in the research, development, and manufacturing of pharmaceuticals, etc. Its reportable segments are Drug discovery and development business and Radiopharmaceutical business.
76GF Score

Get the complete analysis for PPTDF

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.00
Price
$9.54
GF Value